|
C3ORF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.252000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.901400E-01 |
| Normal-vs-Stage2 |
9.442200E-01 |
| Normal-vs-Stage3 |
7.449600E-01 |
| Normal-vs-Stage4 |
6.413200E-01 |
| Stage1-vs-Stage2 |
4.994400E-01 |
| Stage1-vs-Stage3 |
7.588800E-01 |
| Stage1-vs-Stage4 |
8.696400E-01 |
| Stage2-vs-Stage3 |
7.671200E-01 |
| Stage2-vs-Stage4 |
6.264200E-01 |
| Stage3-vs-Stage4 |
7.828600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.348200E-01 |
| Normal-vs-AfricanAmerican |
1.210600E-01 |
| Normal-vs-Asian |
7.719600E-01 |
| Caucasian-vs-AfricanAmerican |
7.957500E-02 |
| Caucasian-vs-Asian |
8.296000E-01 |
| AfricanAmerican-vs-Asian |
3.757800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.050200E-01 |
| Normal-vs-Female |
4.103800E-01 |
| Male-vs-Female |
1.343040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.412600E-01 |
| Normal-vs-Extreme_Weight |
4.545400E-01 |
| Normal-vs-Obese |
3.156600E-01 |
| Normal-vs-Extreme_Obese |
5.898000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.570800E-01 |
| Normal_Weight-vs-Obese |
9.211400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.806800E-01 |
| Extreme_Weight-vs-Obese |
8.065800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.409000E-01 |
| Obese-vs-Extreme_Obese |
2.508000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.191800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.602600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.339800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.155960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.550200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.274000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.288630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.656000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.536400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.640000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.435800E-01 |
| Normal-VS-Type2 PRCC |
2.339700E-02 |
| Normal-VS-KIRP CIMP |
4.865600E-01 |
| Normal-VS-Unclassified PRCC |
8.506200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.116300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.764200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.263800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.102300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.374440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.738800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.716820E-01 |
| Normal-vs-N1 |
8.194200E-01 |
| Normal-vs-N2 |
8.606000E-01 |
| N0-vs-N1 |
5.851600E-01 |
| N0-vs-N2 |
9.848600E-01 |
| N1-vs-N2 |
8.565000E-01 |
|
|
